Merger Agreement

Merger Agreement. Means the Amended and Restated Agreement and Plan of Merger, dated effective as of January 21, 2019, by and among Thunder Bridge Acquisition Ltd., TB Acquisition Merger Sub LLC, Hawk Parent Holdings LLC and, solely in its capacity as the Company Securityholder Representative thereunder, CC Payment Holdings, L.L.C., as it may be amended and supplemented from time to time.

Merger Agreement. Means the agreement and plan of merger dated as of February 27, 2018, as amended, among the Company, Phunware and certain other parties

Merger Agreement. That certain Agreement and Plan of Merger by and among Leo Holdings III Corp., Longleaf Merger Sub, Inc., Longleaf Merger Sub II, LLC and Local Bounti Corporation dated as of June 17, 2021.

Merger Agreement. Means that certain Agreement and Plan of Merger by and among the Company, Parent, Project Marvel First Merger Sub, Inc., Project Marvel Second Merger Sub, LLC and Momentus Inc. dated as of October 7, 2020, as amended, of which Executive has a received copy and has reviewed.

Merger Agreement. Means that certain Agreement and Plan of Merger by and among Social Capital Hedosophia Holdings Corp. III, Asclepius Merger Sub Inc. and Clover Health Investments, Corp. dated October 5, 2020, of which Executive has a received copy and has reviewed.

Merger Agreement. Means that certain Agreement and Plan of Merger and Reorganization, dated as of April 10, 2024, by and among the Company, Tango Merger Sub, Inc., and Tenet Medicines, Inc. and solely in his capacity as equityholder representative, Stephen Thomas.

Merger Agreement. Means certain Agreement and Plan of Merger, dated as of the date hereof, by and among the Company, BTX Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of Parent, BTX Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of Parent, and Adaptive Phage Therapeutics, Inc

Merger Agreement. That certain Business Combination Agreement, dated as of June 4, 2023 as amended by Amendment No 1. to the Business Combination Agreement, dated February 5, 2024 and Amendment No. 2 to the Business Combination Agreement, dated February 14, 2024, by and among Phoenix Biotech Acquisition Corp., a Delaware corporation, CERo Therapeutics, Inc. a Delaware corporation, and PBCE Merger Sub, Inc., a Delaware corporation

Merger Agreement. Has the meaning provided in the recitals to this Agreement.

Merger Agreement. The meaning set forth in the Background to this Agreement